Dr. Nilesh Lalit Vora, MD

Dr. Vora practices at Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System.

Dr. Vora's NPI, 1790976363, was assigned on August 7, 2007. Dr. Vora graduated from Keck School of Medicine of USC in 2004. Dr. Vora's California license number on file is A94183.

Dr. Vora's primary practice is Long Beach Medical Center, at 2801 Atlantic Ave, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 933-2000.

Dr. Vora's primary practice is Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System. Dr. Vora is also affiliated with Orange Coast Medical Center. The medical group on file is MemorialCare Medical Group. Dmand AI also links Dr. Vora to 1 more group practice or clinic, 1 hospice and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vora practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vora's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vora is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Vora's licenses on file in 2 states: California and Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Vora treats.

CMS data shows 1,573 Medicare services from Dr. Vora across 7 procedure codes in 2024, for 319 Medicare patients. Medicare paid $127,162 for them.

CMS counts 319 Medicare patients who saw Dr. Vora in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vora's median patient age at 70, with 59% women.

In 2024, Dr. Vora wrote 192 Medicare Part D claims for 70 patients. 88% of them were for generic drugs. CMS names the drug for 49 of them, across 4 drugs with 11 or more claims each, at $1,452 in total drug cost. In 2023, CMS named 113 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Vora for performance year 2024, reported as part of a group. Dr. Vora accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vora as offering telehealth.

Dmand AI links 2 papers to Dr. Vora in 2017. Dr. Vora's most frequent co-authors are Joseph Chao, MD, Daneng Li, MD and Joanne E. Mortimer, MD.

Dmand AI links Dr. Vora to 2 clinical trials. Conditions studied include Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung and Adenocarcinoma of Lung.

CMS Open Payments shows 324 general payments to Dr. Vora from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 34% of the total. Merck Sharp & Dohme Corporation paid the most, $13,726.

Dr. Vora graduated from Keck School of Medicine of USC in 2004.

Dr. Vora is in network with 15 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.